---
title: "Novo Nordisk drug trials show benefits for weight loss and blood sugar reduction"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267393462.md"
description: "Danish pharmaceutical company Novo Nordisk AS announced that a mid-stage clinical trial of an experimental drug named Amycretin in patients with type 2 diabetes has yielded positive results, showing significant reductions in both weight and blood sugar levels. The company noted that the weight loss drug candidate has been effective in both pill and injection forms. The news drove the company's stock price up more than 3% in the U.S. market"
datetime: "2025-11-25T16:15:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267393462.md)
  - [en](https://longbridge.com/en/news/267393462.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267393462.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/267393462.md) | [繁體中文](https://longbridge.com/zh-HK/news/267393462.md)


# Novo Nordisk drug trials show benefits for weight loss and blood sugar reduction

Danish pharmaceutical company Novo Nordisk (NVO.US) announced that a mid-stage clinical trial of an experimental drug named Amycretin conducted in patients with type 2 diabetes has yielded positive results, showing significant reductions in both weight and blood sugar levels.

The company noted that the weight loss drug candidate has shown effectiveness in both pill and injection forms. The news propelled the company's stock price to rise over 3% in the U.S. market

### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs -- Update](https://longbridge.com/en/news/281201382.md)
- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/en/news/281323250.md)
- [Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program](https://longbridge.com/en/news/280885256.md)
- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/en/news/280694583.md)
- [<![CDATA[Novo Nordisk Launches Multi-Month Subscription Program for Wegovy ]]>](https://longbridge.com/en/news/281216333.md)